Adam Pascale Insider Trading $HEB AIM ImmunoTech Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Adam Pascale.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Adam Pascale. Adam Pascale is CEO in HEMISPHERX BIOPHARMA INC ($HEB) and CFO in HEMISPHERX BIOPHARMA INC ($HEB) and Chief Accounting Officer in HEMISPHERX BIOPHARMA INC ($HEB).
Adam Pascale in AIM ImmunoTech Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Adam Pascale: CEO, CFO, Chief Accounting Officer
Holdings: 112,148 shares
Current Value: $49,345
Latest Transaction: Jun 17 2019
$HEB Market Capitalization: $10.73M
$HEB Previous Close: $0.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Adam Pascale in AIM ImmunoTech Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2019 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Buy | C | 0.00 | 35,000 | 0 | 147,148 | 112.1 K to 147.1 K (+31.21 %) |
| Jun 17 2019 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Buy | C | 0.00 | 50,000 | 0 | 112,148 | 62.1 K to 112.1 K (+80.45 %) |
| Mar 12 2019 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Option Exercise | X | 1,000.00 | 10 | 10,000 | 0 | |
| Mar 12 2019 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Buy | X | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| Mar 12 2019 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Buy | X | 0.00 | 10 | 0 | 10 | 0 to 10 |
| Jan 30 2019 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Option Exercise | A | 0.22 | 142,046 | 31,250 | 142,046 | |
| Nov 29 2018 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Grant | A | 0.00 | 2,500 | 0 | 62,148 | 59.6 K to 62.1 K (+4.19 %) |
| Nov 16 2018 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Option Exercise | A | 0.22 | 1,000 | 220 | 1,000 | |
| Oct 19 2018 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Option Exercise | A | 0.22 | 94,697 | 20,833 | 94,697 | |
| Jul 23 2018 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Buy | P | 0.31 | 32,259 | 10,000 | 59,648 | 27.4 K to 59.6 K (+117.78 %) |
| Jul 19 2018 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Option Exercise | A | 0.31 | 53,763 | 16,667 | 53,763 | |
| May 18 2018 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Option Exercise | A | 0.30 | 83,334 | 25,000 | 83,334 | |
| Apr 19 2018 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Option Exercise | A | 0.38 | 75,000 | 28,500 | 75,000 | |
| Mar 01 2018 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.37 | 123,874 | 45,833 | 123,874 | |
| Sep 01 2017 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.36 | 8,155 | 2,936 | 8,155 | |
| Aug 16 2017 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.41 | 7,112 | 2,916 | 7,112 | |
| Aug 01 2017 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.42 | 6,929 | 2,910 | 6,929 | |
| Jul 17 2017 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.48 | 6,042 | 2,900 | 6,042 | |
| Jul 05 2017 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.49 | 4,738 | 2,322 | 4,738 | |
| Jun 19 2017 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.54 | 4,765 | 2,573 | 4,765 | |
| May 02 2017 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Buy | P | 0.63 | 15,873 | 10,000 | 27,389 | 11.5 K to 27.4 K (+137.83 %) |
| Feb 21 2017 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Buy | P | 0.46 | 6,981 | 3,211 | 11,516 | 4.5 K to 11.5 K (+153.94 %) |
| Jul 29 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.00 | 13,077 | 0 | 13,077 | |
| Jul 19 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.00 | 14,167 | 0 | 14,167 | |
| Jun 30 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CEO | Option Exercise | A | 0.00 | 14,167 | 0 | 14,167 | |
| Jun 30 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CEO | Option Exercise | A | 0.00 | 14,167 | 0 | 14,167 | |
| Jun 23 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.13 | 150,000 | 19,500 | 150,000 | |
| Jun 16 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.00 | 15,455 | 0 | 15,455 | |
| Jun 01 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.00 | 14,167 | 0 | 14,167 | |
| May 16 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.00 | 15,455 | 0 | 15,455 | |
| May 03 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.00 | 12,143 | 0 | 12,143 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.00 | 13,077 | 0 | 13,077 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.00 | 10,625 | 0 | 10,625 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.00 | 10,500 | 0 | 10,500 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.00 | 10,694 | 0 | 10,694 | |
| Apr 19 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.00 | 12,143 | 0 | 12,143 | |
| Dec 09 2014 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | Chief Accounting Of ... | Option Exercise | J | 1.90 | 7,176 | 13,634 | 127,648 |
Page: 1